| Home | << 1 >> |
|
Dirikolu, L., Lehner, A. F., Karpiesiuk, W., Hughes, C., Woods, W. E., Boyles, J., et al. (2003). Detection, quantification, metabolism, and behavioral effects of selegiline in horses. Vet Ther, 4(3), 257–268.
Abstract: Selegiline ([R]-[-]N,alpha-dimethyl-N-2- propynylphenethylamine or l-deprenyl), an irreversible inhibitor of monoamine oxidase, is a classic antidyskinetic and antiparkinsonian agent widely used in human medicine both as monotherapy and as an adjunct to levodopa therapy. Selegiline is classified by the Association of Racing Commissioners International (ARCI) as a class 2 agent, and is considered to have high abuse potential in racing horses. A highly sensitive LC/MS/MS quantitative analytical method has been developed for selegiline and its potential metabolites amphetamine and methamphetamine using commercially available deuterated analogs of these compounds as internal standards. After administering 40 mg of selegiline orally to two horses, relatively low (<60 ng/ml) concentrations of parent selegiline, amphetamine, and methamphetamine were recovered in urine samples. However, relatively high urinary concentrations of another selegiline metabolite were found, tentatively identified as N- desmethylselegiline. This metabolite was synthesized and found to be indistinguishable from the new metabolite recovered from horse urine, thereby confirming the chemical identity of the equine metabolite. Additionally, analysis of urine samples from four horses dosed with 50 mg of selegiline confirmed that N-desmethylselegiline is the major urinary metabolite of selegiline in horses. In related behavior studies, p.o. and i.v. administration of 30 mg of selegiline produced no significant changes in either locomotor activities or heart rates.
Keywords: Administration, Oral; Animals; Behavior, Animal/drug effects; Female; Horses/*metabolism; Mass Spectrometry/veterinary; Monoamine Oxidase Inhibitors/administration & dosage/blood/*pharmacokinetics/pharmacology/urine; Selegiline/administration & dosage/blood/*pharmacokinetics/pharmacology/urine; Substance Abuse Detection/veterinary
|
|
Harkins, J. D., Kamerling, S. G., & Church, G. (1992). Effect of competition on performance of thoroughbred racehorses. J Appl Physiol, 72(3), 836–841.
Abstract: The effect of competition and the influence of age and sex on performance were examined in a study of 18 Thoroughbred racehorses. The horses performed two solo and two competitive runs at 1,200 and 1,600 m for a total of eight runs. No group ran faster during competition, which may have been a reflection of the quality of horses used for this study and their susceptibility to stress-induced impairment of performance. Males showed no significant difference between competitive and solo run times, whereas females were consistently slower during competition. Males ran significantly faster than females in all runs. There was no difference in run times due to age, which may have been due to the high mean age (5.9 yr) of the group. The slower competitive run times may have occurred because of an earlier onset of fatigue when compared with solo runs. Plasma lactate was significantly greater for the 1,200-m competitive than for the solo runs.
|